1. Home
  2. SHPH vs RPGL Comparison

SHPH vs RPGL Comparison

Compare SHPH & RPGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

N/A

Current Price

$3.43

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Republic Power Group Limited Class A Ordinary Shares

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$1.52

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SHPH
RPGL
Founded
2012
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.3M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
SHPH
RPGL
Price
$3.43
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.1K
562.6K
Earning Date
05-11-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.40
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.21
52 Week High
$6.15
$13.06

Technical Indicators

Market Signals
Indicator
SHPH
RPGL
Relative Strength Index (RSI) 48.36 41.31
Support Level $3.29 $0.30
Resistance Level $4.64 $1.99
Average True Range (ATR) 0.25 0.39
MACD -0.04 -0.05
Stochastic Oscillator 29.58 17.67

Price Performance

Historical Comparison
SHPH
RPGL

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

Share on Social Networks: